118 related articles for article (PubMed ID: 1623657)
1. 24-hour efficacy of once-daily diltiazem in essential hypertension.
Massie BM; Der E; Herman TS; Topolski P; Park GD; Stewart WH
Clin Cardiol; 1992 May; 15(5):365-8. PubMed ID: 1623657
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy and safety of once-daily versus twice-daily formulations of diltiazem in the treatment of systemic hypertension. The Canadian Multicenter Diltiazem-CD Hypertension Trial Group.
Ruddy TD; Wright JM; Savard D; Handa SP; Chockalingam A; Boulet AP
Cardiovasc Drugs Ther; 1995 Jun; 9(3):413-20. PubMed ID: 8527351
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive efficacy of optimally titrated doses of once-daily sustained-release diltiazem: a placebo-controlled trial. DILPLACOMP Study Group.
Ollivier JP; Wajman A; Stalla-Bourdillon A
Cardiology; 1995; 86(6):481-7. PubMed ID: 7585759
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of a once daily graded-release diltiazem formulation in essential hypertension.
Glasser SP; Neutel JM; Gana TJ; Albert KS
Am J Hypertens; 2003 Jan; 16(1):51-8. PubMed ID: 12517683
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with a once-daily, extended-release formulation of diltiazem in the treatment of hypertension.
Graney WF
Am J Med; 1992 Aug; 93(2A):56S-64S. PubMed ID: 1519637
[TBL] [Abstract][Full Text] [Related]
6. Trough-to-peak ratio and circadian blood pressure profile after treatment with once-daily extended-release diltiazem, 240 mg, in patients with mild-to-moderate essential hypertension.
Coca A; Sobrino J; Soler J; Módol J; Palos MA; Mínguez A; Esqúe J; Plana J; Cases M; Closas J; de la Sierra A
J Cardiovasc Pharmacol; 1997 Mar; 29(3):316-22. PubMed ID: 9125668
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive efficacy and safe use of once-daily sustained-release diltiazem in the elderly: a comparison with captopril. The Dilcacomp Study Group.
Nicaise J; Neveux E; Blondin P
J Int Med Res; 1995; 23(4):244-53. PubMed ID: 7589767
[TBL] [Abstract][Full Text] [Related]
8. The use of confidence intervals to describe the precision of trough/peak ratios for diltiazem CD in the treatment of hypertension.
Meeves SG; Park GD
J Clin Pharmacol; 1994 Mar; 34(3):231-5. PubMed ID: 8021331
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy of force titrated doses of diltiazem extended-release. A placebo controlled study.
Lacourcière Y; Poirier L; Lefebvre J; Burford RG
Am J Hypertens; 1995 Mar; 8(3):282-6. PubMed ID: 7794578
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive efficacy of night-time graded-release diltiazem versus morning amlodipine in African Americans.
Wright JT; Sica DA; Gana TJ; Bohannon K; Pascual LG; Albert KS
Am J Hypertens; 2004 Sep; 17(9):734-42. PubMed ID: 15363813
[TBL] [Abstract][Full Text] [Related]
11. Twenty-four hour ambulatory blood pressure profile of a new slow-release formulation of diltiazem in mild to moderate hypertension.
Dupont AG; Coupez JM; Jensen P; Coupez-Lopinot R; Schoors DF; Hermanns P; Nicolas M
Cardiovasc Drugs Ther; 1991 Aug; 5(4):701-7. PubMed ID: 1888693
[TBL] [Abstract][Full Text] [Related]
12. Sustained antihypertensive activity of diltiazem SR: double-blind, placebo-controlled study with 24-hour ambulatory blood pressure monitoring.
Whelton A; Eff J; Magner DJ
J Clin Pharmacol; 1992 Sep; 32(9):808-15. PubMed ID: 1430300
[TBL] [Abstract][Full Text] [Related]
13. Optimization of antihypertensive therapy with a novel, extended-release formulation of diltiazem: results of a practice-based clinical study.
Neutel JM; Smith DH; Frishman WH
Clin Ther; 1997; 19(6):1379-93. PubMed ID: 9444447
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive efficacy and tolerability of once-daily sustained-release diltiazem alone and in combination with ramipril in hypertension.
Tuteja R; Swarup D; Saxena GN; Bhandari S; Sharma P
J Assoc Physicians India; 1999 Oct; 47(10):962-5. PubMed ID: 10778687
[TBL] [Abstract][Full Text] [Related]
15. A dose-response trial of once-daily diltiazem.
Felicetta JV; Serfer HM; Cutler NR; Comstock TJ; Huber GL; Weir MR; Hafner K; Park GD
Am Heart J; 1992 Apr; 123(4 Pt 1):1022-6. PubMed ID: 1549966
[TBL] [Abstract][Full Text] [Related]
16. Long-acting diltiazem CD is safe and effective in a hypertensive Mexican-American population.
Herrera CR; Lewin A; Fiddes R; Friedman J; Linn W; Baker T; Balanoff D; Beach CL
Pharmacotherapy; 1997; 17(6):1254-9. PubMed ID: 9399608
[TBL] [Abstract][Full Text] [Related]
17. 24 hour blood pressure control with once-daily versus twice-daily formulations of diltiazem.
Ruddy TD; Wright JM; Savard D; Handa SP; Chockalingam A; Fischer L; Boulet AP
Cardiovasc Drugs Ther; 1995 Dec; 9(6):799-807. PubMed ID: 8850385
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of blood pressure response to the combination of enalapril (single dose) and diltiazem ER (four different doses) in systemic hypertension.
Applegate WB; Cohen JD; Wolfson P; Davis A; Green S
Am J Cardiol; 1996 Jul; 78(1):51-5. PubMed ID: 8712118
[TBL] [Abstract][Full Text] [Related]
19. Diltiazem compared with metoprolol as add-on-therapies to diuretics in hypertension. Swedish Diltiazem-Metoprolol Multicentre Study Group.
Thulin T; Hedner T; Gustafsson S; Olsson SO
J Hum Hypertens; 1991 Apr; 5(2):107-14. PubMed ID: 2072368
[TBL] [Abstract][Full Text] [Related]
20. A randomized, controlled trial comparing diltiazem, hydrochlorothiazide, and their combination in the therapy of essential hypertension.
Pool PE; Applegate WB; Woehler T; Sandall P; Cady WJ
Pharmacotherapy; 1993; 13(5):487-93. PubMed ID: 8247917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
